On September 2, 2026 Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix" or the "Company"), a fully integrated, commercial-stage biopharmaceutical company, reported that the management team will participate in a fireside chat and 1x1s at Cantor’s 2026 Global Healthcare Conference, being held September 9-11, 2026, in New York.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor’s 2026 Global Healthcare Conference
Fireside Chat
Presenter: Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals
Date: September 10, 2026
Presentation Time: 3:55-4:25 p.m. ET

A live webcast and replay will be available under the News & Events tab in the Investors section of the Tonix website at View Source

(Press release, TONIX Pharmaceuticals, SEP 2, 2026, View Source [SID1234670537])

On September 2, 2026 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, reported that Dean Schorno, the company’s chief financial officer, will participate in the following investor conferences in September:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2026 Biopharma Back to School Conference in New York, NY
Rigel will participate in one-on-one meetings on Wednesday, September 9.

Cantor Global Healthcare Conference 2026 in New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Thursday, September 10, at 11:30 a.m. ET.

H.C. Wainwright 28th Annual Global Investment Conference in New York, NY
Rigel will participate in one-on-one meetings and present a company overview on Tuesday, September 15, at 10:00 a.m. ET.
To access the live webcasts or archived recordings of the Cantor and H.C. Wainwright conference presentations, visit the Investor Relations section of the company’s website at www.rigel.com. Please connect to Rigel’s website prior to the start of the live webcast to allow for any software downloads.

(Press release, Rigel, SEP 2, 2026, View Source [SID1234670536])

On September 2, 2026 Merck (NYSE: MRK), known as MSD outside of the United States and Canada, reported that Caroline Litchfield, executive vice president and chief financial officer, and Dr. Dean Y. Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, Sept. 09, 2026, at 2:15 p.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at this weblink.

(Press release, Merck & Co, SEP 2, 2026, View Source [SID1234670535])

On September 2, 2026 Mabqi reported the participation of Anne Chevrel, Johanna Marines and Cécile Durand in the Festival of Biologics 2026, taking place from October 13 to 15 in Basel, Switzerland—Europe’s largest biologics event.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Our company will showcase its latest advances with a strong presence at this year’s congress.
Not 1 but 2 oral presentations!
– Next-Generation Tumor-Specific Anti-CD30 ADC as a New Therapy in Hemato-Oncology – Anne Chevrel, Head of Discovery – Wednesday, October 14 at 12.10.
– A Novel Pan-Cancer TRPV6-Targeted Therapy Driving Antitumor Activity Through Ion Channel Modulation– Johanna Marines, Head of Preclinical Development, Wednesday, October 14 at 12.30.

Two Poster presentations:
– MQI-201: A pan cancer immunotherapy targeting TRPV6 to convert cold tumors into hot tumors
– MQI-181: Tumor-specific anti-CD30 ADC limiting sink effect and demonstrating enhanced in vivo efficacy

Don’t miss the opportunity to meet our team at our booth in the Choose France Pavillon. Feel free to drop us a line or to schedule or contacts us through the networking app to schedule a meeting.

This major international gathering brings together over 3,000 experts from across the biologics and ATMP value chain, covering everything from early-stage discovery to commercialization. The event spans antibody therapies, cell and gene therapies, immunotherapies, and biosimilars.
We’re proud to be part of this vibrant community of scientists, innovators, and industry leaders shaping the future of large molecule therapeutics.

(Press release, Mabqi, SEP 2, 2026, View Source [SID1234670534])

On September 2, 2026 Mabqi reported its CEO Sylvain Yon, will attend the 26th Annual Biotech in Europe Forum, taking place in Basel on October 7–8 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Held as part of Sachs Autumn Life Sciences Week, the forum will bring together senior executives, investors, entrepreneurs and industry experts from across the global life sciences ecosystem.

The event will provide a valuable opportunity to discuss with investors and biopharmas, explore strategic partnerships and connect with companies developing the next generation of healthcare innovations.

Sylvain Yon looks forward to meeting industry peers, investors and potential partners in Basel.

Feel free to drop us a line or to schedule or contacts us through the networking app to schedule a meeting.

(Press release, Mabqi, SEP 2, 2026, View Source [SID1234670533])